NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com started coverage on shares of NovaBay Pharmaceuticals (NYSE:NBY) in a research report issued to clients and investors on Tuesday. The firm set a “sell” rating on the stock.

NovaBay Pharmaceuticals Trading Down 11.0 %

NYSE NBY opened at $0.07 on Tuesday. The company’s fifty day simple moving average is $0.13 and its 200-day simple moving average is $0.22. NovaBay Pharmaceuticals has a 52 week low of $0.07 and a 52 week high of $1.52. The stock has a market cap of $2.64 million, a P/E ratio of -0.02 and a beta of 1.97.

NovaBay Pharmaceuticals (NYSE:NBY) last posted its earnings results on Tuesday, March 26th. The company reported ($0.95) EPS for the quarter. NovaBay Pharmaceuticals had a negative return on equity of 150.14% and a negative net margin of 65.46%. The firm had revenue of $3.73 million for the quarter. On average, research analysts expect that NovaBay Pharmaceuticals will post -0.41 EPS for the current fiscal year.

Institutional Trading of NovaBay Pharmaceuticals

An institutional investor recently bought a new position in NovaBay Pharmaceuticals stock. Armistice Capital LLC purchased a new position in NovaBay Pharmaceuticals, Inc. (NYSE:NBY) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 718,768 shares of the company’s stock, valued at approximately $147,000. Armistice Capital LLC owned about 11.01% of NovaBay Pharmaceuticals at the end of the most recent quarter. 23.25% of the stock is currently owned by institutional investors.

NovaBay Pharmaceuticals Company Profile

NovaBay Pharmaceuticals, Inc, a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands.